about
Role of voltage-gated sodium, potassium and calcium channels in the development of cocaine-associated cardiac arrhythmiasUpdate on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug developmentCalculate the QT interval in patients taking drugs for dementiaModeling and Simulation Approaches for Cardiovascular Function and Their Role in Safety AssessmentOptimal antiarrhythmic drug therapy for electrical stormA study of early afterdepolarizations in a model for human ventricular tissue.Screening system for drug-induced arrhythmogenic risk combining a patch clamp and heart simulator.Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trialsTreating arrhythmias with adjunctive magnesium: identifying future research directionsOverdose of atypical antipsychotics: clinical presentation, mechanisms of toxicity and managementAcute effects of sex steroid hormones on susceptibility to cardiac arrhythmias: a simulation studyPharmacometabolomic approach to predict QT prolongation in guinea pigsChanges in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trialA Framework of Knowledge Integration and Discovery for Supporting Pharmacogenomics Target Predication of Adverse Drug Events: A Case Study of Drug-Induced Long QT SyndromeDrug- and non-drug-associated QT interval prolongation.Evaluation of an in silico cardiac safety assay: using ion channel screening data to predict QT interval changes in the rabbit ventricular wedge.Generalized estimating equations for genome-wide association studies using longitudinal phenotype data.Early assessment of proarrhythmic risk of drugs using the in vitro data and single-cell-based in silico models: proof of concept.Cardiac side effects of psychiatric drugs.A suspected case of carbimazole-associated torsades de pointesQT Prolongation Complicated with Torsades de Pointes in Prosthetic Mitral Valve Endocarditis: A Case ReportOverdrive pacing in a patient with incessant torsades de pointes.Importance of QT interval in clinical practice.A new homogeneous high-throughput screening assay for profiling compound activity on the human ether-a-go-go-related gene channel.State-dependent blockade of human ether-a-go-go-related gene (hERG) K(+) channels by changrolin in stably transfected HEK293 cells.The association of serum testosterone levels and ventricular repolarizationRisk of QT prolongation and torsade de pointes associated with exposure to hydroxyzine: re-evaluation of an established drug.The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance.No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a 'thorough QT/QTc study' performed according to ICH guidelines.Antibiotic precautions in athletesDisease-associated QT-shortage versus quinine associated QT-prolongation: age dependent ECG-effects in Ghanaian children with severe malaria.Erythromycin, QTc interval prolongation, and torsade de pointes: Case reports, major risk factors and illness severityA novel genetic modifier for clarithromycin-related cardiac arrhythmia risk?Domperidone-induced dystonia: a rare and troublesome complicationhERG-related drug toxicity and models for predicting hERG liability and QT prolongation.Electrocardiograms (ECGs) in phase I anticancer drug development: the MD Anderson Cancer Center experience with 8518 ECGsAnalysis of Relationship between Levofloxacin and Corrected QT Prolongation Using a Clinical Data Warehouse.Selective serotonin reuptake inhibitors and torsade de pointes: new concepts and new directions derived from a systematic review of case reportsUse of clarithromycin and roxithromycin and risk of cardiac death: cohort studyA common variant of NOS1AP is associated with QT interval duration in a Chinese population with Type 2 diabetes.
P2860
Q24634668-B8932A7D-9BB2-4760-86B5-8AD4D46E27BBQ24646866-062504C2-1B19-474E-9562-EA682881D857Q24683903-7AA3E548-E78F-4089-A825-A6C72F6B6CB0Q26801610-9A1852F7-5443-4705-A8E4-58AEA6F3776BQ27027096-184FFEA3-4730-437B-8F66-637F85B58674Q27335021-804CEB68-DBBB-4DB4-A59E-EACE4F3872D5Q27343160-F4D582D5-4C00-49B7-A622-59E5EDB4E8A8Q28071256-3EC3C28B-5F2E-460E-8C13-AA33A9A0FEE7Q28078430-B88CBEEB-D08A-4BF8-93CE-FDCACC4D36FBQ28268128-DA110647-C55B-48EC-BE3F-84AD8E431C3BQ28472692-34719B84-0C59-4BEA-8764-AF2F49E63502Q28485993-37B425C5-D88E-4879-89C9-52936B85C350Q28539543-F71C1649-151D-4A86-B018-40FDC17B504CQ28661910-58B6B490-2DBD-45E7-9136-CEA42BFD7C33Q30474909-75ED8C2C-8692-4117-8948-C289F8B8920CQ30620268-5A1C97F9-060A-422A-AB1A-1307ABCFD20DQ30858387-F6A72329-3F99-4DDD-86B3-92F00E31906EQ31140927-5701CB14-4F3B-479D-AA3C-F6251E1A11B0Q33155805-897A3C5D-27D1-4AC6-A1C5-8DCB140CE8A0Q33158936-0865F2AE-2B50-4D36-B291-7A97339962EDQ33161933-E37C5060-6390-4069-9E98-8D2EBE573D3FQ33163390-A4546FD2-8CD0-4BDE-9AF2-074D8D27882CQ33165222-9D2B9C8E-5C0C-484E-B9E9-9FF0823CBE2FQ33479407-2F09ACFC-50A0-4EF7-88BE-99CD0196B331Q33557841-C5A67FCF-5EF3-4AF3-B5A0-91F63F35762FQ33596419-229F325B-1B1E-478D-8004-C99D87E2BA90Q33635283-0DE815C0-4589-4104-B843-F720A825B3D7Q33661017-84A1850A-C760-48FB-9933-A1B66A55E54AQ33765011-1E493212-E55F-4087-BAA2-CDBD2123D3E0Q33786181-D45D9098-48C7-41A4-BDCF-35D4EB79BD42Q33794334-EB3955CD-11EE-4FA6-ABF2-0C027B45AD7AQ33810580-9985A3DB-FABA-417E-8452-40B5384C081FQ33810586-66F573AC-4C19-4882-AE2C-2B34F2E1080DQ33833735-9708ACDC-312E-40D2-B032-0A3D3981529CQ33845924-2564DE9B-FE6A-4D29-95AC-9CA10119E3BDQ33883248-904FD250-C7E7-4E1D-B0E3-B2E8D8175577Q33983552-EA6B8A6A-466F-4E8E-9CD7-80CA105AF094Q34016220-C488CF6C-E5A3-4171-9655-943C7BD7E2E8Q34041767-507CCDA1-9CF6-49B7-8353-6E95CBC6C5EFQ34078226-87E1EBF8-1EB7-4B29-83A0-5DC98B315664
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Drug induced QT prolongation and torsades de pointes
@ast
Drug induced QT prolongation and torsades de pointes
@en
Drug induced QT prolongation and torsades de pointes
@nl
type
label
Drug induced QT prolongation and torsades de pointes
@ast
Drug induced QT prolongation and torsades de pointes
@en
Drug induced QT prolongation and torsades de pointes
@nl
prefLabel
Drug induced QT prolongation and torsades de pointes
@ast
Drug induced QT prolongation and torsades de pointes
@en
Drug induced QT prolongation and torsades de pointes
@nl
P2860
P3181
P356
P1433
P1476
Drug induced QT prolongation and torsades de pointes
@en
P2093
A John Camm
Yee Guan Yap
P2860
P304
P3181
P356
10.1136/HEART.89.11.1363
P407
P577
2003-11-01T00:00:00Z